The Natural Progression of Parkinson’s Disease in a Small Cohort with 15 Drug-na?ve Patients

被引:0
|
作者
Liu Ying
Fan Jin-Hu
Gao Xiang
Ma Li
Qiao You-Lin
Zhang Lin
机构
[1] USA
[2] Chinese Academy of Medical Sciences and Peking Union Medical College
[3] Dalian Municipal Friendship Hospital
[4] Boston
[5] Cancer Hospital
[6] and Harvard Medical School
[7] China
[8] MA 02115
[9] Brigham and Women’s Hospital
[10] Channing Laboratory
[11] Liaoning 116001
[12] CA 95817
[13] University of California Davis School of Medicine
[14] Department of Nutrition
[15] Harvard University School of Public Health
[16] Department of Neurology
[17] Department of Cancer Epidemiology
[18] Department of Medicine
[19] Sacramento
[20] Beijing 100021
关键词
Drug-na?ve; Epidemiology; Parkinson’s Disease; Progression;
D O I
暂无
中图分类号
R742.5 [震颤麻痹综合征];
学科分类号
1002 ;
摘要
Background: The studies of the natural progression of Parkinson’s disease (PD) in Chinese populations have been lacking. To address this issue and obtain a preliminary data, we conducted a PD progression assessment in 15 adults withde novo PD from a nutritional intervention trial (NIT) cohort in Lin County China.Methods: Using the Copiah County screening questionnaire and United Kingdom Parkinson’s Disease Society Brain Bank diagnostic criteria, we surveyed the available NIT cohort members in 2000 and diagnosed 86 patients as PD. In 2010, we resurveyed all PD patients and confirmed definite PD diagnosis in 15 cases with the rest of them being dead (54); having probable (10) PD or vascular Parkinsonism (3); refusing to participate (2); or being away (2). In both surveys, we used Hoehn and Yahr (HY) scale and assessed the disease progression. Unified Parkinson’s Disease Rating Scale (UPDRS) was added to the second survey.Results: In 2010, the average disease duration for 15 definite PD patients was 13.6 ± 7.3 years. Over a 10-year time span, 9 out of 15 patients remained at the same HY stage while the remaining 6 progressed. Rigidity (47% vs. 100%;P = 0.002) and postural instability (7% vs. 47%;P = 0.005) worsened significantly. The mean UPDRS motor scores in 2010 were 39.4 ± 23.7.Conclusions: Overall worsening of motor function in PD seems to be the rule in this untreated cohort, and their rate of progression seemed to be slower than those reported in the western populations.
引用
收藏
页码:1761 / 1764
页数:4
相关论文
共 50 条
  • [41] Has drug therapy changed the natural history of Parkinson's disease?
    Clarke, C. E.
    JOURNAL OF NEUROLOGY, 2010, 257 : S262 - S267
  • [42] Fatigue in a cohort of geriatric patients with and without Parkinson's disease
    Goulart, F. O.
    Godke, B. A.
    Borges, V.
    Azevedo-Silva, S. M. C.
    Mendes, M. F.
    Cendoroglo, M. S.
    Ferraz, H. B.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (08) : 771 - 775
  • [43] Non-steroidal anti-inflammatory drug use and markers of Parkinson's disease progression: A retrospective cohort study
    Kuhlman, Greg
    Auinger, Peggy
    Duff-Canning, Sarah
    Lang, Anthony
    Tanner, Caroline
    Marras, Connie
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 454
  • [44] Exposure to household pesticides and Parkinson's disease in the Parkinson's Progression Markers Initiative cohort
    Santos-Lobato, Bruno Lopes
    Schuh, Artur Francisco S.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [45] Beta Agonists and Progression of Parkinson's Disease in Older Adults: A Retrospective Cohort Study
    Marras, Connie
    Pequeno, Priscila
    Austin, Peter C.
    Gershon, Andrea S.
    Iqbal, Javaid
    Rochon, Paula A.
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2020, 35 (07) : 1275 - 1277
  • [46] Prevalence and risk factors of overweight and obesity in Chinese patients with first-episode drug-na?ve major depressive disorder
    Si, Tong
    Yang, Kun
    Lang, XiaoE
    Dong, Xinglu
    Wang, Ningqun
    Zhang, Xiangyang
    Qu, Miao
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 286 : 351 - 359
  • [47] Prevalence and risk factors for psychotic symptoms in young, first-episode and drug-naïve patients with major depressive disorder
    Wu, Yuxuan
    Zhao, Xueli
    Li, Zhe
    Yang, Ruchang
    Peng, Ruijie
    Zhou, Yue
    Xia, Xingzhi
    Deng, Hanxu
    Zhang, Xiaobin
    Du, Xiangdong
    Zhang, Xiangyang
    BMC PSYCHIATRY, 2024, 24 (01)
  • [48] Drug therapy in patients with Parkinson's disease
    Thomas Müller
    Translational Neurodegeneration, 1 (1)
  • [49] Drug therapy in patients with Parkinson's disease
    Mueller, Thomas
    TRANSLATIONAL NEURODEGENERATION, 2012, 1
  • [50] Progression of small vessel disease correlates with cortical thinning in Parkinson's disease
    Foo, Heidi
    Mak, Elijah
    Yong, Ting Ting
    Wen, Ming-Ching
    Chander, Russell Jude
    Au, Wing Lok
    Tan, Louis
    Kandiah, Nagaendran
    PARKINSONISM & RELATED DISORDERS, 2016, 31 : 34 - 40